






Semax
10mg
100.00$
Semax is studied for its involvement in cognitive function, neuroprotection, and stress-response signaling pathways. Research models often explore how this peptide influences memory formation, learning processes, and neural signaling efficiency.
Semax
Product Name: Semax
Type: Cognitive & Neuroprotective Research Peptide
Research Focus:
Semax is a synthetic heptapeptide analog of ACTH(4–10) developed in Russia and studied primarily for cognitive enhancement and neuroprotection[1][2]. While intranasal administration is most common in clinical literature, subcutaneous injection offers a convenient once‑daily alternative for research purposes[1][4]. This educational protocol presents a practical SC approach using straightforward reconstitution for accurate insulin‑syringe measurements.
Research Interest:
- Cognitive performance and memory pathway research
- Neuroplasticity and brain-derived neurotrophic factor (BDNF) studies
- Stress adaptation and resilience signaling models
- Focus, attention, and mental clarity pathways
Scientific Interest:
- Neurotrophic factor regulation
- Synaptic plasticity mechanisms
- Central nervous system signaling pathways
Reconstitution:
Reconstitute: Add 3.0 mLbacteriostatic water (max vial capacity) → ~3.33 mg/mLconcentration.
Typical daily range: 300–800 mcgonce daily (gradual titration recommended).
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles[2][9].
Cycle:
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
WEEK | DAILY DOSE (MCG) | UNITS (PER INJECTION) (ML) |
|---|---|---|
Weeks 1–2 | 300 mcg | 9 units (0.09 mL) |
Weeks 3–4 | 500 mcg | 15 units (0.15 mL) |
Weeks 5–6 | 600 mcg | 18 units (0.18 mL) |
Weeks 7–8 | 800 mcg | 24 units (0.24 mL) |
For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.
Frequency: Inject once dailysubcutaneously[1][4]. This schedule uses the largest practical dilution (3.0 mL) to ensure per‑injection volumes are accurate and manageable. Most human nootropic studies use intranasal dosing in the range of 400–900 mcg/day divided into multiple administrations[2][3]; this SC protocol delivers comparable total daily amounts in a single injection for convenience.
Reconstitution Steps
Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake vigorously).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light[2].
IMPORTANT NOTICE:
This product is intended strictly for laboratory research. It is not intended to diagnose, treat, cure, or prevent any disease.

